NFAT-dependent genes with differential expression in UCB versus AB CD4+ T cells
Gene symbol . | Accession no. . | Gene name . | 0 h . | 6 h . | 16 h . |
---|---|---|---|---|---|
p21 | NM_000389 | Cyclin-dependent kinase inhibitor 1A (p21, Cip 1) | — | −2.64* | − 2.46* |
CSF2 (GM-CSF) | M11734 | Colony-stimulating factor 2 (granulocyte-macrophage) | — | −6.96* | −2.14* |
CTLA-4 | NM_005214 | Cytotoxic T-lymphocyte-associated protein 4 | — | −4.00* | −5.28* |
CTLA-4 | BG536887 | Cytotoxic T-lymphocyte-associated protein 4 | −2.30* | −4.92* | −6.50* |
CTLA-4 | U90273 | Cytotoxic T-lymphocyte-associated protein 4 | −2.30* | −4.92* | −7.46* |
CTLA-4 | AI733018 | Cytotoxic T-lymphocyte-associated protein 4 | −3.25* | −5.28* | −6.06* |
IFN-γ | M29383 | Interferon, gamma | −2.14* | −10.56* | −9.19* |
IL-2Rα | NM_000417 | Interleukin 2 receptor, alpha | −2.14* | — | — |
IL-3 | NM_000588 | Interleukin 3 (colony-stimulating factor, multiple) | — | −12.13* | −5.66* |
IL-4 | NM_000589 | Interleukin 4 | — | −6.50* | −3.73* |
IL-4 | NM_000589 | Interleukin 4 | — | −8.00* | −4.00* |
IL-5 | NM_000879 | Interleukin 5 (colony-stimulating factor, eosinophil) | — | −17.15* | −8.00* |
IL-13 | NM_002188 | Interleukin 13 | — | −3.73* | −3.48* |
TNF | NM_000594 | Tumor necrosis factor (TNF superfamily, member 2) | — | −2.46* | — |
TNFSF5 (CD40L) | NM000074 | Tumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome) | — | −2.30* | −2.30* |
MIP-1α | NM_002983 | CCL2 | — | −4.59* | −4.00* |
CCNA2 | NM_001237 | Cyclin A2 | — | — | 8.57 |
CCNE2 | AF112857 | Cyclin E2 | — | — | 2.46 |
CCNE2 | NM_004702 | Cyclin E2 | — | — | 3.25 |
Gene symbol . | Accession no. . | Gene name . | 0 h . | 6 h . | 16 h . |
---|---|---|---|---|---|
p21 | NM_000389 | Cyclin-dependent kinase inhibitor 1A (p21, Cip 1) | — | −2.64* | − 2.46* |
CSF2 (GM-CSF) | M11734 | Colony-stimulating factor 2 (granulocyte-macrophage) | — | −6.96* | −2.14* |
CTLA-4 | NM_005214 | Cytotoxic T-lymphocyte-associated protein 4 | — | −4.00* | −5.28* |
CTLA-4 | BG536887 | Cytotoxic T-lymphocyte-associated protein 4 | −2.30* | −4.92* | −6.50* |
CTLA-4 | U90273 | Cytotoxic T-lymphocyte-associated protein 4 | −2.30* | −4.92* | −7.46* |
CTLA-4 | AI733018 | Cytotoxic T-lymphocyte-associated protein 4 | −3.25* | −5.28* | −6.06* |
IFN-γ | M29383 | Interferon, gamma | −2.14* | −10.56* | −9.19* |
IL-2Rα | NM_000417 | Interleukin 2 receptor, alpha | −2.14* | — | — |
IL-3 | NM_000588 | Interleukin 3 (colony-stimulating factor, multiple) | — | −12.13* | −5.66* |
IL-4 | NM_000589 | Interleukin 4 | — | −6.50* | −3.73* |
IL-4 | NM_000589 | Interleukin 4 | — | −8.00* | −4.00* |
IL-5 | NM_000879 | Interleukin 5 (colony-stimulating factor, eosinophil) | — | −17.15* | −8.00* |
IL-13 | NM_002188 | Interleukin 13 | — | −3.73* | −3.48* |
TNF | NM_000594 | Tumor necrosis factor (TNF superfamily, member 2) | — | −2.46* | — |
TNFSF5 (CD40L) | NM000074 | Tumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome) | — | −2.30* | −2.30* |
MIP-1α | NM_002983 | CCL2 | — | −4.59* | −4.00* |
CCNA2 | NM_001237 | Cyclin A2 | — | — | 8.57 |
CCNE2 | AF112857 | Cyclin E2 | — | — | 2.46 |
CCNE2 | NM_004702 | Cyclin E2 | — | — | 3.25 |
Criteria for inclusion were as follows: at least one present (P) call and FC ≥ 2 and change call ≠ no change (NC). A negative number (*) indicates lower expression in UCB than AB; a positive number, higher expression in UCB than AB; —, the gene did not meet inclusion criteria at that time point; and genes with multiple results indicate multiple probe sets for that gene on the microarray.